Airway Disease in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a common condition affecting approximately 1% of the general population. RA is a multisystem disorder that causes progressive articular destruction through synovial inflammation. One of the most common extraarticular manifestations of RA is pulmonary involvement, where a...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the American Thoracic Society Vol. 19; no. 3; pp. 343 - 352
Main Authors Matson, Scott M, Demoruelle, M Kristen, Castro, Mario
Format Journal Article
LanguageEnglish
Published United States American Thoracic Society 01.03.2022
Subjects
Airway management
Arthritis, Rheumatoid - complications
Focused Reviews
Humans
Inflammation
Inflammation - complications
Lung diseases
Lung Diseases, Interstitial - diagnosis
Lung Diseases, Interstitial - etiology
Lung Diseases, Interstitial - therapy
Pulmonology
Respiration Disorders
Rheumatoid arthritis
Risk Factors
asthma
bronchiectasis
rheumatoid arthritis
bronchiolitis
COPD
Online AccessGet full text

Cover

More Information
Summary:Rheumatoid arthritis (RA) is a common condition affecting approximately 1% of the general population. RA is a multisystem disorder that causes progressive articular destruction through synovial inflammation. One of the most common extraarticular manifestations of RA is pulmonary involvement, where all compartments of the pulmonary system can be impacted (e.g., pulmonary vasculature, pleura, parenchyma, and the airways). Although it has been known for decades that a portion of patients with RA develop interstitial lung disease, and recent advancements in understanding the genetic risk and treatment for RA-interstitial lung disease have drawn attention, more recent data have begun to highlight the significance of airway disease in patients with RA. Yet, little is known about the underlying pathogenesis, clinical impact, or optimal treatment strategies for airway disease in RA. This review will focus on airway disease involvement in patients with RA by highlighting areas of clinical inquiry for pulmonologists and rheumatologists and discuss areas for future research. Finally, we discuss a potential screening algorithm for providers when approaching patients with RA with respiratory complaints.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2329-6933
2325-6621
DOI:10.1513/AnnalsATS.202107-876CME